Brian Ferguson

Dr. Brian Ferguson is a Professor and Principal Investigator at the Cambridge Immunology Network and affiliated with the Department of Pathology at the University of Cambridge. His research program focuses on understanding the fundamental mechanisms of innate immunity, particularly in the context of viral infections and vaccine development.

Dr. Ferguson's research interests encompass several critical areas of immunological investigation:

• Mechanisms of pathogen detection by the innate immune system
• DNA sensing pathways and interferon production
• Poxvirus immune evasion strategies
• Vaccinology and vaccine optimization
• Host-pathogen molecular interactions
• Role of self and foreign DNA in immune activation

Analysis of Dr. Ferguson's recent publications (2021-2025) reveals a consistent research trajectory focused on understanding how viruses interact with host immune sensing mechanisms. His work demonstrates particular expertise in poxviruses (especially vaccinia virus) and their sophisticated immune evasion tactics. A notable trend across his recent work is the exploration of DNA-PK's critical role in viral DNA sensing and immune evasion, alongside investigations into MDA5 variants, TLR21 function in avian species, and the gut-lung immunity axis. His research bridges fundamental immunological mechanisms with translational applications for vaccine development.

Dr. Ferguson's laboratory has made significant contributions to understanding:

• The molecular mechanisms by which DNA activates innate immune responses
• How viral proteins specifically target host signaling pathways like NF-κB
• The complex relationship between viral infection, DNA damage response, and immune activation
• Comparative immunology across different species, particularly avian models
• The interplay between microbiome composition and vaccine responses

As a member of the Cambridge Immunology Network Steering Committee, Dr. Ferguson plays an active role in shaping immunological research directions at Cambridge. His work is supported by major research funding bodies including the Medical Research Council and British Society for Immunology, reflecting the significance and impact of his research in the field of innate immunity and viral pathogenesis.